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One reason for monitoring social inequalities in health is to
evaluate whether the health effects of social or public health
policies may differ by social position. The paper in this issue by
Rachet et al (2010) aims to assess whether the NHS Cancer Plan
has reduced social inequalities in cancer survival, and they
generally conclude that it has not. There is much to commend in
this study. The authors provide a comprehensive picture across
more- and less-common cancers, disaggregated by gender and
using up-to-date techniques for measuring cancer survival. They
also measure relative survival using deprivation-specific life tables
to estimate background mortality, which helps to guard against
artifactual changes in survival inequalities that may arise if
inequalities in background mortality are changing over time
(Rachet et al, 2009). Their use of relatively small geographic units
of analysis (approximately 1500 persons) to define deprivation as a
proxy for individual socioeconomic position likely provides less
misclassification than would larger areas such as electoral wards.
In addition, although they measure relative survival as an outcome,
in terms of inequalities in survival they present estimates of the
absolute rather than the relative socioeconomic difference in
survival rates. This latter point is important because secular trends
in relative and absolute measures of health inequality often
disagree (Moser et al, 2007), and absolute differences are typically
seen reflecting the population health burden of inequalities.
Much more could be said about the positive aspects of this study
(and the authors larger body of work on cancer surveillance) than
its limitations, but a few methodological points are of interest. First
is the issue of inequality measurement. Rachet and colleagues
present only information on the survival trends of the most- and
least-deprived quintiles of the population, which ignores the 60%
of the population in the middle deprivation categories. One could
argue that estimating the gap between the upper and lower quintile
provides a legitimate summary of the extent of socioeconomic
inequality, but knowing what’s happening to the rest of the
population also matters, as different patterns may be hidden by
the same high-low gap, and may suggest different strategies
for reducing inequalities. It is important to know, for example,
whether the deprivation gap primarily results from a graded
association between deprivation and survival, from an advantaged
group that is doing considerably better than the rest of the popula-
tion, or from a disadvantaged group that is doing considerably
worse that the other 80% of the population. One could argue that
the latter case may suggest a more troubling situation, if this indicates
inadequate or lack of timely treatment (Raine et al, 2010). The point
is that the range as a measure of inequality cannot identify these
distinct patterns. I would encourage the authors in future work to
complement their analysis of gaps using a summary measure of
inequality that accounts for the full distribution of socioeconomic
position and its association with cancer survival.
A second methodological limitation is the use of an ecological
measure of deprivation as a proxy for individual-level information.
The lack of individual-level measures of socioeconomic position
necessitates this choice (unfortunately common in cancer surveil-
lance), but it could potentially lead to underestimation of
socioeconomic inequalities in survival. In the United States, for
example, most cancer mortality gradients are considerably steeper
when measured using individual rather than area-based socio-
economic indicators (Singh et al, 2003; Albano et al, 2007). And
though trends in small-area deprivation inequality are likely to
reflect the situation among individuals, the choice of indicator
likely matters. Using longitudinal data from the Office of National
Statistics, Sloggett et al (2007) found that the magnitude of the
effect of socioeconomic position on cancer survival differed
whether it was measured using individual or area-based indicators,
though all indicators generally show poorer survival for the
disadvantaged. The use of area-based indicators also by Rachet
and colleagues also creates the potential for confounding by
health-selected migration. If healthier individuals are more likely
to move to less-deprived areas, this could potentially lead to
increases in area-based health inequalities over time. The use
of 1-year survival may make this less likely, but given evidence
for this phenomenon for other health outcomes in the United
Kingdom (Boyle, 2004; Cox et al, 2007) and elsewhere (Pearce and
Dorling, 2010), it may be worth investigating further.
Third, it’s worth emphasising that the estimates presented by
Rachet and colleagues are model based, and thus subject to
modelling assumptions. For good reason they attempted to
estimate period-specific linear trends to isolate pre-Cancer plan,
post-initialisation, and post-implementation differences. However,
it’s not clear whether this particular periodization provides a good
fit to the data (there is also little discussion of how the periods of
initialisation and implementation were distinguished). Commend-
ably, they also experimented with a more flexible modelling
strategy, but I disagree slightly with the authors that the trends and
conclusions are identical using the two strategies. For example,
using linear models Figure 2B supports their conclusion that the
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www.bjcancer.compost-cancer plan, but the supplementary graph using a more
flexible methods shows that the trends were constant over the
entire period of study, and no change in inequality by period is
evident. In the supplementary web table, the estimate of the change
in the rectal cancer survival gap among women from 1996 to 2006
is a 0.7 percentage point increase in the gap when using a linear
model, but a 0.8 percentage point decrease in the gap when
measured using non-linear regression (the respective estimates for
men are also different at 2.0 and 0.3). Similar differences in both
the magnitude and the direction of change of the deprivation gap
using linear versus non-linear models are evident for a number of
other cancers (pancreas, bladder, melanoma, larynx). In short,
although the modelling scheme may lead to generally similar
conclusions for all cancers combined, for several specific cancers
the results seem quite sensitive to model specification.
These methodological issues notwithstanding, I am inclined to
agree with Rachet and colleagues that there is little evidence that
the NHS Cancer Plan has yet to reduce inequalities in cancer
survival. Very few of the estimates of the annual change in the
deprivation gap for specific cancers for any one of the authors’
phases of the NHS plan statistically exclude zero (at conventional
levels), and it seems unlikely that tests of whether the annual
change differs between pre- and post-phases (arguably a better test
of whether the plan is working) would show any effect. However,
my view of the overall secular trend is somewhat more positive
than that of the authors. If one ignores the potentially artificial
designation between initialisation and implementation and looks
at the entire period from 1996–2000 to 2004–2006, the results in
Table 2 suggest that 21 of the 35 cancer-gender combinations are at
least going in the right direction (i.e., decreasing inequality),
though they are imprecisely estimated and may also reflect ceiling
effects. Furthermore, inequalities in 1-year survival have improved
for cancers with good prognosis for both men and women, and
3-year survival inequalities for both good and poor-prognosis
cancers have improved for women. Rachet and colleagues are
correct that this is no cause for celebration, as the magnitude of
survival inequalities remains far too high to the disadvantage of
poor areas, but one could nevertheless read these results as
showing at least some progress toward success. This progress,
however, seems largely the result of continued improvements in
cancer survival for all social groups that have been occurring since
at least the mid-1980s rather than the direct result of the NHS
Cancer Plan. It may still be too early to tell whether the plan will
ultimately succeed in reducing inequalities, but finding out will
require the continuation of high-quality monitoring studies like
that of Rachet and colleagues.
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